Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) EBIT Margin (2016 - 2026)

Bio-Techne has reported EBIT Margin over the past 17 years, most recently at 18.41% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 244.0% year-over-year to 18.41%; the TTM value through Dec 2025 reached 9.62%, down 712.0%, while the annual FY2025 figure was 8.38%, 945.0% down from the prior year.
  • EBIT Margin for Q4 2025 was 18.41% at Bio-Techne, up from 16.63% in the prior quarter.
  • Over five years, EBIT Margin peaked at 2815.85% in Q3 2022 and troughed at 7.53% in Q2 2025.
  • A 5-year average of 160.08% and a median of 22.62% in 2021 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: soared 279132bps in 2022 and later plummeted -279568bps in 2023.
  • Year by year, EBIT Margin stood at 23.15% in 2021, then grew by 8bps to 25.0% in 2022, then plummeted by -44bps to 13.94% in 2023, then rose by 15bps to 15.96% in 2024, then grew by 15bps to 18.41% in 2025.
  • Business Quant data shows EBIT Margin for TECH at 18.41% in Q4 2025, 16.63% in Q3 2025, and 7.53% in Q2 2025.